Silverarc Capital Management, LLC Cytokinetics Inc Transaction History

Silverarc Capital Management, LLC

  • $402 Million
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024
BUY
$63.75 - $108.06 $3.19 Million - $5.4 Million
50,000 New
50,000 $3.51 Million
Q4 2022

Feb 14, 2023
BUY
$35.77 - $51.11 $625,975 - $894,425
17,500 New
17,500 $801,000
Q1 2022

May 13, 2022
SELL
$29.74 - $46.0 $1.73 Million - $2.68 Million
-58,190 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$34.35 - $46.38 $305,062 - $411,900
8,881 Added 18.01%
58,190 $2.65 Million
Q3 2021

Nov 15, 2021
BUY
$18.54 - $35.74 $914,188 - $1.76 Million
49,309 New
49,309 $1.76 Million

Others Institutions Holding CYTK

# of Institutions
410
Shares Held
125M
Call Options Held
4.6M
Put Options Held
2.43M
View Full List

About CYTOKINETICS INC

CYTK Quotes by TradingView
  • Ticker CYTK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 94,144,096
  • Market Cap $4.9B
  • Description
  • Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...
More about CYTK
Track This Portfolio

Track Silverarc Capital Management, LLC Portfolio

Follow Silverarc Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Silverarc Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Silverarc Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email